![Terry Fry](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Terry Fry
Corporate Officer/Principal bei SANA BIOTECHNOLOGY, INC.
Ursprung des Netzwerks ersten Grades von Terry Fry
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
Public Company | Biotechnology | 27 | |
National Cancer Institute
![]() National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous National Cancer Institute provides healthcare services. It specializes in different cancer treatment such as adrenocortical carcinoma, anal cancer, appendix cancer, skin cancer, breast cancer, cardiac tumors, endometrial cancer, and gallbladder cancer. The company was founded in March 1937 and is headquartered in Bethesda, MD.
5
| Non-Profit Organization | Investment Trusts/Mutual Funds | 5 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Terry Fry
Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
---|---|---|---|
JUNO THERAPEUTICS INC | Biotechnology | Director/Board Member Corporate Officer/Principal Founder Director of Finance/CFO General Counsel Founder Human Resources Officer Chief Tech/Sci/R&D Officer Corporate Officer/Principal Director of Finance/CFO Corporate Officer/Principal | |
Massachusetts Institute of Technology | College/University | Undergraduate Degree Corporate Officer/Principal Doctorate Degree Doctorate Degree | |
X-Body, Inc.
![]() X-Body, Inc. BiotechnologyHealth Technology X-BODY, Inc. provides biotechnological research services. The company was founded on April 9, 2009 and is headquartered in Waltham, MA. | Biotechnology | Director/Board Member Director/Board Member President | |
Flagship Pioneering
![]() Flagship Pioneering Investment ManagersFinance Flagship Pioneering (Flagship Pioneering) is a venture capital firm founded in 1982 by Ed M Kania and Noubar B Afeyan. The firm is headquartered in Cambridge, Massachusetts. | Investment Managers | Private Equity Investor Private Equity Investor Private Equity Analyst | |
US Food & Drug Administration
![]() US Food & Drug Administration General GovernmentGovernment US Food & Drug Administration operates agencies to protect health and human services. It protects and promotes public health through the control and supervision of food safety, tobacco products, dietary supplements, prescription and over-the-counter pharmaceutical drugs, vaccines, biopharmaceuticals, blood transfusions, medical devices, electromagnetic radiation emitting devices, cosmetics, animal foods and feed and veterinary products. The company was founded by Theodore Roosevelt and Harvey Washington Wiley on 30th June, 1906 and is headquartered in Silver Spring, MD. | General Government | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Director/Board Member Director/Board Member | |
Genzyme Corp.
![]() Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Director/Board Member Corporate Officer/Principal | |
Repertoire Immune Medicines, Inc.
![]() Repertoire Immune Medicines, Inc. Miscellaneous Commercial ServicesCommercial Services Repertoire Immune Medicines, Inc. operates as a clinical-stage biotechnology company. It focuses on the immune system to prevent, treat, and cure cancer, autoimmune disorders, and infectious diseases. The company was founded by Noubar Afeyan and is headquartered in Cambridge, MA. | Miscellaneous Commercial Services | Chairman Director/Board Member | |
Harvard Medical School | College/University | Corporate Officer/Principal Doctorate Degree | |
Genentech, Inc.
![]() Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal | |
MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
GOSSAMER BIO, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
McGill University | College/University | Undergraduate Degree Undergraduate Degree | |
Boston University | College/University | Doctorate Degree Doctorate Degree | |
National Resilience, Inc.
![]() National Resilience, Inc. Miscellaneous Commercial ServicesCommercial Services National Resilience, Inc. is a biopharmaceutical manufacturing and technology company, which engages in the development of vaccines. It offers virus production, formulations, RNA modalities, and CMC development. The company was founded in 2020 and is headquartered in La Jolla, CA. | Miscellaneous Commercial Services | Director/Board Member Chairman | |
SIENNA BIOPHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Founder | |
The Johns Hopkins University School of Medicine | College/University | Doctorate Degree Doctorate Degree | |
Altos Labs, Inc.
![]() Altos Labs, Inc. BiotechnologyHealth Technology Altos Labs is a biotechnology company that focuses on cellular rejuvenation programming to restore cell health and resilience. The company is based in Redwood City, CA. The company's goal is to reverse disease and transform medicine. Altos Labs was founded by Rick Klausner and Hans Edgar Bishop. The CEO is Hal V. Barron. | Biotechnology | Director/Board Member Founder | |
ARRAY TECHNOLOGIES, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
AGIOS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
RECEPTOS INC | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Cornell University
![]() Cornell University Other Consumer ServicesConsumer Services Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY. | College/University | Undergraduate Degree Doctorate Degree | |
SYROS PHARMACEUTICALS, INC. | Biotechnology | Director/Board Member Founder | |
DENALI THERAPEUTICS INC. | Biotechnology | Director/Board Member Director/Board Member | |
GRAIL LLC
![]() GRAIL LLC Medical/Nursing ServicesHealth Services GRAIL, Inc. is a healthcare company. It engages in the development of a technology for early detection of cancer. The company was founded by Jeffrey T. Huber, William H. Rastetter, and Mostafa Ronaghi on September 11, 2015 and is headquartered in Menlo Park, CA. | Medical/Nursing Services | Director/Board Member Chief Executive Officer | |
Fred Hutchinson Cancer Research Center
![]() Fred Hutchinson Cancer Research Center Miscellaneous Commercial ServicesCommercial Services Fred Hutchinson Cancer Research Center is a non-profit organization which provides research and testing services. The company was founded in 1965 and is headquartered in Seattle, WA. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
LYELL IMMUNOPHARMA, INC. | Biotechnology | Director/Board Member Director/Board Member | |
CELGENE | Biotechnology | Director/Board Member Corporate Officer/Principal | |
Acepodia Biotechnologies, Ltd.
![]() Acepodia Biotechnologies, Ltd. BiotechnologyHealth Technology Acepodia Biotechnologies, Ltd. engages in the development of cell therapies to treat patients with cancers. Its business information includes biotechnology service industry, intellectual property rights, and wholesale and retail trade of chemical raw materials. The company was founded by Patrick Yang, and by Sonny Hsiao on June 19, 2017 and is headquartered in Taipei, Taiwan. | Biotechnology | Founder Director/Board Member | |
JW Biotechnology (Shanghai) Co. Ltd. | Director/Board Member Director/Board Member | ||
University of Toronto | College/University | Graduate Degree Graduate Degree | |
BIOGEN INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Director/Board Member | |
College of the Holy Cross (Massachusetts) | College/University | Director/Board Member Undergraduate Degree | |
T2 BIOSYSTEMS, INC. | Medical Specialties | Director/Board Member Founder | |
LOXO ONCOLOGY INC | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
JW Therapeutics (Shanghai) Co., Ltd.
![]() JW Therapeutics (Shanghai) Co., Ltd. BiotechnologyHealth Technology JW Therapeutics (Shanghai) Co., Ltd. engages in biopharmaceutical industry. It focuses on the development, transformation, and promotion of cell-based immunotherapies to treat cancer. The company was founded by Yi Ping Li on February 18, 2016 and is headquartered in Shanghai, China. | Biotechnology | Founder Director/Board Member | |
Cobalt Biomedicine, Inc.
![]() Cobalt Biomedicine, Inc. Pharmaceuticals: MajorHealth Technology Cobalt Biomedicine, Inc. engages in the development of therapeutic based drugs. The company was founded in 2017 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | President Chief Executive Officer | |
Cytoimmune Therapeutics, Inc.
![]() Cytoimmune Therapeutics, Inc. BiotechnologyHealth Technology Cytoimmune Therapeutics, Inc. is a clinical-stage biotechnology company founded in 2017 and based in Toa, Japan. The American company is focused on developing a pipeline of NK cell therapies for various types of cancer, including lung cancer, acute myeloid leukemia, solid tumors, and multiple myeloma. The private company's lead product, Cyto-102, is a track-NK cell therapy that aims to enter clinical trials in combination with atezolizumab for non-small cell lung cancer in 2022. Cytoimmune Therapeutics also offers cell therapy development and clinical manufacturing services to biotechnology companies and academia. The company's state-of-the-art clinical cell manufacturing facility is custom-built to support the development and commercialization of cutting-edge T cell or NK cell therapies. The company was founded in 2017 by Michael A. Caligiuri, William Michael Rosellini, and Jianhua Yu, Ph.D. José Eduardo Vidal has been the CEO of the company since 2021. | Biotechnology | Director/Board Member | |
Challenge Seattle | Chairman | ||
Ophirex, Inc.
![]() Ophirex, Inc. Miscellaneous Commercial ServicesCommercial Services Ophirex, Inc. develops antidotes to snakebite. The company was founded by Jerry D. Harrison and Matthew Lewin and is headquartered in Corte Madera, CA. | Miscellaneous Commercial Services | Director/Board Member | |
European Biopharmaceutical Enterprises
![]() European Biopharmaceutical Enterprises BiotechnologyHealth Technology European Biopharmaceutical Enterprises develops biological products. The private company is based in Brussels, Belgium. | Biotechnology | Corporate Officer/Principal | |
Dendreon Pharmaceuticals, Inc.
![]() Dendreon Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Dendreon Pharmaceuticals, Inc. discovers, develops and commercializes novel products for the treatment of cancer. The company is headquartered in Olympia, WA. | Medical Specialties | Chief Operating Officer | |
JW (CAYMAN) THERAPEUTICS CO. LTD | Biotechnology | Director/Board Member | |
Viewray Technologies, Inc.
![]() Viewray Technologies, Inc. Miscellaneous Commercial ServicesCommercial Services Viewray Technologies, Inc. develops radiation therapy technology for the treatment of cancer. It operates through the MRIdian system software. The company was founded by James F. Dempsey and Russell S. Donda in March 2004 and is headquartered in Oakwood Village, OH. | Miscellaneous Commercial Services | Director/Board Member | |
William Blair & Co. LLC (Investment Management)
![]() William Blair & Co. LLC (Investment Management) Investment ManagersFinance William Blair & Co. LLC (Investment Management) (William Blair-IM) is the investment management division of William Blair & Co. LLC, a registered broker/dealer headquartered in Chicago, Illinois. The firm was founded in 1935 and is a wholly owned subsidiary of WBC Holdings LP. William Blair-IM provides investment advisory and management services to a number of clients including high net worth clients, individuals, small institutions, William Blair Wrap Program clients and other registered investment advisers. | Investment Managers | Chairman | |
Bayer HealthCare Pharmaceuticals, Inc.
![]() Bayer HealthCare Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Bayer HealthCare Pharmaceuticals, Inc. manufactures pharmaceutical drugs. It offers pharmaceuticals and therapeutics in the areas of diagnostic imaging, hematology and cardiology, cancer, women's health and several other chronic diseases such as multiple sclerosis and Parkinson's disease. Bayer HealthCare Pharmaceuticals was founded in 1979 and is located in Wayne, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal |
Statistik
International
Vereinigte Staaten | 44 |
China | 4 |
Kanada | 3 |
Taiwan | 2 |
Belgien | 2 |
Sektoral
Health Technology | 30 |
Consumer Services | 8 |
Commercial Services | 6 |
Finance | 5 |
Government | 2 |
Operativ
Director/Board Member | 253 |
Corporate Officer/Principal | 94 |
Independent Dir/Board Member | 68 |
Founder | 49 |
Chief Executive Officer | 30 |
Am stärksten vernetzte Beziehungen
Insiders | |
---|---|
Robert Nelsen | 80 |
Maggie Wilderotter | 44 |
Douglas Cole | 44 |
Patrick Yang | 28 |
Douglas Williams | 25 |
Hans Bishop | 24 |
Richard Mulligan | 19 |
Michelle Seitz | 18 |
Josh Bilenker | 18 |
Sunil Agarwal | 17 |
Geoffrey von Maltzahn | 15 |
Andrew Mazar | 14 |
Alise Reicin | 13 |
Steven Harr | 11 |
Norman Sharpless | 11 |